Therapeutic Options for Lymphangioleiomyomatosis (LAM): Where We Are and Where We Are Going

F1000 Medicine Reports

doi 10.3410/m1-93

Full Text

Abstract

Available in

Date

Authors

Publisher

F1000 Research Ltd

Related search

Sequence Analysis: Where Are We, Where Are We Going?

Sequence Analysis and Related Approaches
2018English

Where Are We Going?

American Journal of Orthodontics and Dentofacial Orthopedics
Orthodontics
2015English

Where Are We Going ... ?

Scandinavian Journal of Occupational Therapy
EnvironmentalPublic HealthOccupational Health
2014English

Antisperm Contraceptive Vaccines: Where We Are and Where We Are Going?

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2011English

Molecular Targeted Agents--Where We Are and Where We Are Going

Chinese Journal of Cancer
2013English

Pulmonary Arterial Hypertension: Where Are We and Where Are We Going?

Advances in Pulmonary Hypertension
2009English

Where Have We Been and Where Are We Going?

1998English

Liver Transplantation Today: Where We Are Now and Where We Are Going

Liver Transplantation
HepatologyTransplantationSurgery
2018English

Cytologic-Histologic Correlation: Where Are We Now, and Where Are We Going?

Cancer cytopathology
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy